Eosinophilic asthma (e-asthma) is a rare form of the breathing disease that can be very hard to treat successfully. That can put you in a frustrating cycle of asthma attacks. People with e-asthma are ...

Please provide your email address to receive an email when new articles are posted on . There were no significant differences in the incidence of the first exacerbation event between the biologics.

Some people with very severe asthma symptoms have a condition called eosinophilic asthma. People with this type of asthma may need to use inhaled medicines along with a newer type of medicine that is ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the MANDARA Phase III trial showed AstraZeneca’s FASENRA (benralizumab) met the primary endpoint of the trial and demonstrated ...

Discover a study exploring how high serum TSLP influences adult asthma and implications for targeted treatment.

AstraZeneca has imagined a swarm of annoying anthropomorphized eosinophils—a type of white blood cell that causes airway inflammation and asthma symptoms—mucking around and ruining everything in their ...

A new study has found that using biologic therapy to reduce lung inflammation enabled 92% of people with severe asthma to reduce their dose of daily inhaled steroid without exacerbating their symptoms ...

Please provide your email address to receive an email when new articles are posted on . A cohort of patients with atopic disease showed a high rate of gastrointestinal symptoms including food ...

"With regard to the prevalence of comorbidities, the burden associated with severe [non-eosinophilic] asthma was heavy due to more comorbidities. Allergic asthma is as frequent in [eosinophilic] as in ...